---
figid: PMC9587781__ars.2021.0125_figure6
pmcid: PMC9587781
image_filename: ars.2021.0125_figure6.jpg
figure_link: /pmc/articles/PMC9587781/figure/f6/
number: FIG. 6
figure_title: ''
caption: Anaphylatoxin receptor inhibitors in preclinical studies of diabetic kidney
  disease. A summary of preclinical studies that have shown promise using anaphylatoxin
  receptor inhibitors in rodent models of type 1 and type 2 diabetes, each with their
  advantages and disadvantages. Color images are available online.
article_title: 'The Complement Pathway: New Insights into Immunometabolic Signaling
  in Diabetic Kidney Disease.'
citation: Sih Min Tan, et al. Antioxid Redox Signal.  October 2022;37(10-12):781-801.
year: '2022'

doi: 10.1089/ars.2021.0125
journal_title: Antioxidants & Redox Signaling
journal_nlm_ta: Antioxid Redox Signal
publisher_name: Mary Ann Liebert, Inc., publishers

keywords:
- complement
- kidney
- diabetes
- immunometabolism

---
